References
Antzelevitch, C., Pollevick, G. D., Cordeiro, J. M., Casis, O., Sanguinetti, M. C., Aizawa, Y., et al. (2007). Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation, 115, 442–449.
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., et al. (2018). Prevalence of autism spectrum disorder among children aged 8 years—Autism and developmental disabilities monitoring network, 11 Sites, United States, 2014. Morbidity and Mortality Weekly Report Surveillance Summaries, Washington, DC 2002(67), 1–23.
Betancur, C. (2011). Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting. Brain Research, 1380, 42–77.
Breitenkamp, A. F., Matthes, J., & Herzig, S. (2015). Voltage-gated calcium channels and autism spectrum disorders. Current Molecular Pharmacology, 8, 123–132.
Breitenkamp, A. F., Matthes, J., Nass, R. D., Sinzig, J., Lehmkuhl, G., Nürnberg, P., et al. (2014). Rare mutations of CACNB2 found in autism spectrum disease-affected families alter calcium channel function. PLoS ONE, 9, e95579.
Buraei, Z., & Yang, J. (2013). Structure and function of the β subunit of voltage-gated Ca2+ channels. Biochimica et Biophysica Acta, 1828, 1530–1540.
Cordeiro, J. M., Marieb, M., Pfeiffer, R., Calloe, K., Burashnikov, E., & Antzelevitch, C. (2009). Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome. Journal of Molecular and Cellular Cardiology, 46, 695–703.
Despang, P., Salamon, S., Breitenkamp, A., Kuzmenkina, E., Herzig, S., & Matthes, J. (2020). Autism-associated mutations in the CaVβ2 calcium-channel subunit increase Ba2+-currents and lead to differential modulation by the RGK-protein Gem. Neurobiology of Disease, 136, 104721.
Doan, R. N., Lim, E. T., De Rubeis, S., Betancur, C., Cutler, D. J., Chiocchetti, A. G., et al. (2019). Recessive gene disruptions in autism spectrum disorder. Nature Genetics, 51, 1092–1098.
Giorda, R., Bonaglia, M. C., Beri, S., Fichera, M., Novara, F., Magini, P., et al. (2009). Complex segmental duplications mediate a recurrent dup(X)(p11.22-p11.23) associated with mental retardation, speech delay, and EEG anomalies in males and females. American Journal of Human Genetics, 85, 394–400.
Herzig, S., Khan, I. F. Y., Gründemann, D., Matthes, J., Ludwig, A., Michels, G., et al. (2007). Mechanism of Ca(v)1.2 channel modulation by the amino terminus of cardiac beta2-subunits. FASEB Journal, 21, 1527–1538.
Heyes, S., Pratt, W. S., Rees, E., Dahimene, S., Ferron, L., Owen, M. J., et al. (2015). Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Progress in Neurobiology, 134, 36–54.
Iossifov, I., O’Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., et al. (2014). The contribution of de novo coding mutations to autism spectrum disorder. Nature, 515, 216–221.
Latronico, A. C., Brito, V. N., & Carel, J.-C. (2016). Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinology, 4, 265–274.
Lu, A. T.-H., Dai, X., Martinez-Agosto, J. A., & Cantor, R. M. (2012). Support for calcium channel gene defects in autism spectrum disorders. Molecular Autism, 3, 18.
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., et al. (2007). Strong association of de novo copy number mutations with autism. Science, 316, 445–449.
Severi, G., Bernardini, L., Briuglia, S., Bigoni, S., Buldrini, B., Magini, P., et al. (2016). New patients with Temple syndrome caused by 14q32 deletion: Genotype-phenotype correlations and risk of thyroid cancer. American Journal of Medical Genetics A, 170A, 162–169.
Spergel, D. J. (2007). Calcium and small-conductance calcium-activated potassium channels in gonadotropin-releasing hormone neurons before, during, and after puberty. Endocrinology, 148, 2383–2390.
Splawski, I., Timothy, K. W., Decher, N., Kumar, P., Sachse, F. B., Beggs, A. H., et al. (2005). Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proceedings of the National Academy of Sciences United States of America, 102, 8089–8096.
Splawski, I., Timothy, K. W., Sharpe, L. M., Decher, N., Kumar, P., Bloise, R., et al. (2004). Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell, 119, 19–31.
Van Petegem, F., Clark, K. A., Chatelain, F. C., & Minor, D. L. (2004). Structure of a complex between a voltage-gated calcium channel beta-subunit and an alpha-subunit domain. Nature, 429, 671–675.
Weiner, D. J., Wigdor, E. M., Ripke, S., Walters, R. K., Kosmicki, J. A., Grove, J., et al. (2017). Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders. Nature Genetics, 49, 978–985.
Wemhöner, K., Friedrich, C., Stallmeyer, B., Coffey, A. J., Grace, A., Zumhagen, S., et al. (2015). Gain-of-function mutations in the calcium channel CACNA1C (Cav1.2) cause non-syndromic long-QT but not Timothy syndrome. Journal of Molecular and Cellular Cardiology, 80, 186–195.
Acknowledgments
We are grateful to the patient and her parents for their participation. This work was partially supported by Telethon Grant n. GGP15171 to Elena Bonora.
Author information
Authors and Affiliations
Contributions
CG conceived and designed the study, analyzed the data, and wrote the paper. PD performed the elecrtophysiological studies and contributed to the writing of the paper. FP, TP, FI performed the sequencing and bioinformatic analyses. GS, AP, AC provided the patient data. JM performed the elecrtophysiological studies and contributed to the writing of the paper. EB supervised the research and co-wrote the paper. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Informed Consent
Informed consent for genetic analysis and publication of results was obtained from the patient’s parents in compliance with national ethics regulation.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Figure 1
CACNB2 p.Arg70Cys mutation. (a) Representation of CACNB2 homozygous mutation (Integrative Genomic Viewer, IGV) identified by WES in the proband. (b) Electropherograms of the sequences of parents (heterozygous carriers) and proband (homozygous patient). (c) GTEx Portal Expression profiles for CACNB2 isoforms: the different exons and expressed transcripts are displayed. Color intensity represents the level of transcript expression, calculated as Transcripts Per Million (TPM), in the specified tissue. The majority of CACNB2 transcripts expressed in heart does not include exon 2a, where the p.Arg70Cys variant maps (red arrow) (PPTX 903 kb)
Rights and permissions
About this article
Cite this article
Graziano, C., Despang, P., Palombo, F. et al. A New Homozygous CACNB2 Mutation has Functional Relevance and Supports a Role for Calcium Channels in Autism Spectrum Disorder. J Autism Dev Disord 51, 377–381 (2021). https://doi.org/10.1007/s10803-020-04551-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-020-04551-y